Disseminated peritoneal leiomyomatosis: Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation

American Journal of Pathology

Volumn 150, Issue 6, 1997, Pages 2153-2166

  Quade, Bradley J ^a   McLachlin, Catherine M ^b   Soto Wright, Valena ^a   Zuckerman, James ^a   Mutter, George L ^a   Morion, Cynthia C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; CYTOGENETICS; FEMALE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEIOMYOMATOSIS; PERITONEUM TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOOTH MUSCLE; X CHROMOSOME INACTIVATION;

ADULT; CHROMOSOME DELETION; DNA METHYLATION; DOSAGE COMPENSATION, GENETIC; FEMALE; HETEROZYGOTE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; KALLMANN SYNDROME; KARYOTYPING; LEIOMYOMATOSIS; MICROSATELLITE REPEATS; PERITONEAL NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; X CHROMOSOME;

EID: 0030921958     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Tavassoli FA, Norris HJ: Peritoneal leiomyomatosis (leiomyomatosis peritonealis disseminata): a clinico-pathologic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol 1982, 1:59-74
2. Erbstöber VE, Lessel W: Disseminated peritoneal leiomyomatosis: case contribution to the differential diagnosis of benign multiple peritoneal neoplasms. Zentralb Chir 1982, 107:223-226
3. Mansour F, Darai E, Felgeres A, Meicler P, Pinet C, Colau JC: La léiomyomatose péritonéale disséminée: a propos d'un cas. Rev Fr Gynécol Obstét 1992, 87:431-433
4. Nguyen GK: Disseminated leiomyomatosis peritonealis: report of a case in a postmenopausal woman. Can J Surg 1993, 36:46-48
5. Kökcü A, Alvur Y, Baris YS, Kuskonmaz I: Leiomyomatosis peritonealis disseminata, Acta Obstet Gynecol Scand 1994, 73:81-83
6. Hrabowska M, Kadylak B: Leiomyomatosis peritonealis disseminata in a fetus. Zentralb Allg Pathol Pathol Anat 1989, 135:685-688
7. Kitazawa S, Shiraishi N, Maeda S: Leiomyomatosis peritonealis disseminata with adipocytic differentiation. Acta Obstet Gynecol Scand 1992, 71:482-484
8. Willson JR, Peale AR: Multiple peritoneal leiomyomas associated with a granulosa cell tumor of the ovary. Am J Obstet Gynecol 1952, 64:204-208
9. Aterman K, Fraser GM, Lea RH: Disseminated peritoneal leiomyomatosis. Virchows Arch A Pathol Anat Histopathol 1977, 374:13-26
10. Pieslor PC, Orenstein JM, Hogan DL, Breslow A: Ultrastructure of myofibroblasts and decidualized cells in leiomyomatosis peritonealis disseminata. Am J Clin Pathol 1979, 72:875-882
11. Fujii S, Okamura H, Nakashima N, Bann C, Aso T, Nishimura T: Leiomyomatosis peritonealis disseminata. Obstet Gynecol 1980, 55:79S-83S
12. Lim OW, Segal A, Ziel HK: Leiomyomatosis peritonealis disseminata associated with pregnancy. Obstet Gynecol 1980, 55:122-125
13. Sutherland JA, Wilson EA, Edger DE, Powell D: Ultrastructure and steroid-binding studies in leiomyomatosis peritonealis disseminata. Am J Obstet Gynecol 1980, 136:992-996
14. Ström H, Jacobson L, Hedberg K: Leiomyomatosis peritonealis disseminata, Acta Obstet Gynecol Scand 1981, 60:421-423
15. Walley VM: Leiomyomatosis peritonealis disseminata. Int J Gynecol Pathol 1983, 2:222-223
16. Düe W, Píckartz H: immunohistologic detection of estrogen and progesterone receptors in disseminated peritoneal leiomyomatosis. Int J Gynecol Pathol 1989, 8:46-53
17. Thejls H, Pettersson B, Nordlinder H: Leiomyomatosis peritonealis disseminata. Acta Obstet Gynecol Scand 1986, 65:373-374
18. Hales HA, Peterson CM, Jones KP, Quinn JD: Leiomyomatosis peritonealis disseminata treated with a gonadotropin-releasing hormone agonist: a case report. Am J Obstet Gynecol 1992, 167:515-516
19. Ma KF, Chow LT: Sex cord-like pattern leiomyomatosis peritonealis disseminata: a hitherto undescribed feature. Histopathology 1992, 21:389-391
20. Aruh I, Taskin O, Demir N: Recurrent leiomyomatosis peritonealis disseminata. Int J Gynaecol Obstet 1993, 43:330-331
21. Rubin SC, Wheeler JE, Mikuta JJ: Malignant leiomyomatosis peritonealis disseminata. Obstet Gynecol 1986, 68:126-129
22. Akkerdijk GJM, Flu PK, Giard RWM, van Lent M, Wallenburg HCS: Malignant leiomyomatosis peritonealis disseminata. Am J Obstet Gynecol 1990, 163:591-593
23. Abulafia O, Angel C, Sherer DM, Fultz PJ, Bonfiglio TA, DuBeshter B: Computed tomography of leiomyomatosis peritonealis disseminata with malignant transformation. Am J Obstet Gynecol 1993, 169:52-54
24. Parmley TH, Woodruff JD, Winn K, Johnson JW, Douglas PH: Histogenesis of leiomyomatosis peritonealis disseminata (disseminated fibrosing deciduosis). Obstet Gynecol 1975, 46:511-516
25. Goldberg MF, Hurt WG, Frable WJ: Leiomyomatosis peritonealis disseminata: report of a case and review of the literature. Obstet Gynecol 1977, 49:46-52
26. Büttner A, Bässler R, Theele C: Pregnancy-associated ectopic decidua (deciduosis) of the greater omentum: an analysis of 60 biopsies with cases of fibrosing deciduosis and leiomyomatosis peritonealis disseminata. Pathol Res Pract 1993, 189:352-359
27. Cramer SF, Patel A: The nonrandom regional distribution of uterine leiomyomas: a clue to histogenesis? Hum Pathol 1992, 23:635-638
28. Carlson KJ, Nichols DH, Schiff I: Indications for hysterectomy. N Engl J Med 1993, 28:856-860
29. Graves EJ: National Hospital Discharge Survey: Annual Summary, 1990, Vital and Health Statistics. Washington, DC, Government Printing Office, 1992, Series 13, No. 112
30. Pokras P, Hunfnagel VG: Hysterectomies in the Unites States, 1965-84, Vital and Health Statistics. Washington, DC, Government Printing Office, 1987, Series 13, No. 92
31. Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94:435-438
32. Hendrickson MR, Kempson RL: The uterine corpus. Diagnostic Surgical Pathology, Edited by SS Sternberg, DA Antonioli, D Carter, JC Eggleston, SE Mills, HA Oberman. New York, Raven Press, 1989, pp 1591-1654
33. Fletcher JA, Morton CC, Paelka K, Lage JM: Chromosome aberration in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability. Cancer Res 1990, 50:4092-4097
34. Silverberg SG, Kurman RJ: Smooth muscle and other mesenchymal tumors. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Edited by J Rosai, LH Sobin, Washington, DC, Armed Forces Institute of Pathology, 1992, pp 113-151
35. Sreekantaiah C, Davis JR, Sandberg AA: Chromosomal abnormalities in leiomyosarcomas. Am J Pathol 1993, 142:293-305
36. Bell SW, Kempson RL, Hendrickson MR: Problematic uterine smooth muscle neoplasms: a clinicopathotogic study of 213 cases. Am J Surg Pathol 1994, 18:535-558
37. Peters WA III, Howard DR, Andersen WA, Figge DC: Uterine smooth-muscle tumors of uncertain malignant potential, Obstet Gynecol 1994, 83:1015-1020
38. Konrad P, Mellblom L: Intravenous leiomyomatosis. Acta Obstet Gynecol Scand 1989, 68:371-376
39. Clement PB, Young RH, Scully RE: Intravenous leiomyomatosis of the uterus: a clinicopathological analysis of 16 cases with unusual histologic features. Am J Surg Pathol 1988, 12:932-945
40. Norris HJ, Parmley T: Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis: a clinical and pathologic study of 14 cases. Cancer 1975, 36:2164-2178
41. Nakayama Y, Kitamura S, Kawachi K, Kawata T, Fukutomi M, Hasegawa JM, R: Intravenous leiomyomatosis extending into the right atrium. Cardiovasc Surg 1994, 2:642-645
42. Mulvany NJ, Slavin JL, Ostor AG, Fortune DW: Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 22 cases. Int J Gynecol Pathol 1994, 13:1-9
43. Cohen JD, Robins HI: Response of "benign" metastasizing leiomyoma to progestin withdrawal: case report. Eur J Gynaecol Oncol 1993, 14:44-45
44. Parenti DJ, Morley TF, Giudice JC: Benign metastasizing leiomyoma: a case report and review of the literature, Respiration 1992, 59:347-350
45. Hafiz MA, Wang KP, Berkman A: Fine needle aspiration diagnosis of benign metastasizing leiomyoma of the lung: a case report. Acta Cytologica 1994, 38:398-402
46. Linder D, Gartler SM: Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas, Science 1965, 150:67-69
47. Townsend DE, Sparkes RS, Baluda MC, McClelland G: Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 1970, 107: 1168-1173
48. Nilbert M, Strombeck B: Independent origin of uterine leiomyomas with karyotypically identical alterations. Gynecol Obstet Invest 1992, 33:246-248
49. Mashal RD, Schoenberg Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, Sklar J: Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in development of leiomyomata. Genes Chromosomes & Cancer 1994, 11:1-6
50. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B: Clonal origin of bladder cancer. N Engl J Med 1992, 326:737-740
51. Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BAJ, Humphrey P, Berchuck A, Ponder BAJ, Bast RC: Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation. J Natl Cancer Inst 1992, 84:1793-1798
52. Li S, Man H, Resnik E, Carcangiu ML, Schwartz PE, Yang-Feng TL: Advanced ovarian carcinoma: molecular evidence of unifocal origin. Gynecol Oncol 1993, 51:21-25
53. Tsao S, Mok C, Knapp RC, Oike K, Muto MG, Welch WR, Goodman HM, Sheets EE, Berkowitz RS, Ching CL: Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol 1993, 48:5-10
54. Bonsing BA, Devilee P, Cleton-Jansen A, Kuipers-Dijkshoorn N, Fleuren GJ, Cornelisse CJ: Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas. Cancer Res 1993, 53: 3804-3811
55. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW: Methylation of Hpa II and Hha I sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992, 51:1229-1239
56. Mutter GL, Chaponot ML, Fletcher JA: A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol 1995, 146:501-508
57. Mutter GL, Boynton KA: PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies. Nucleic Acids Res 1995, 23:1411-1418
58. Mutter GL, Boynton KA: X chromosome inactivation in the normal female genital tract: implications for identification of neoplasia. Cancer Res 1995, 55:5080-5084
59. Sargent MS, Weremowicz S, Rein MS, Morton CC: Translocations in 7q22 define a critical region in uterine leiomyomata. Cancer Genet Cytogenet 1994, 77: 65-68
60. Sleddens HFBM, Oostra BA, Brinkman AC, Trapman J: Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res 1992, 20:1427
61. Naumova AK, Plenge RM, Bird LM, Leppert M, Morgan K, Willard HF, Sapienza C: Heritability of X chromosome-inactivation phenotype in a large family. Am J Hum Genet 1996, 58:1111-1119
62. Fujii S, Nakashima N, Okamura H, Takenaka A, Kanzaki H, Okuda YMK, Nishimura T: Progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced by estrogen: experimental approach to leiomyomatosis peritonealis disseminata. Am J Obstet Gynecol 1981, 139:164-172
63. Fujii S: Experimental approach to leiomyomatosis peritonealis disseminata: progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced by estrogen. Acta Obstet Gynaecol Jpn 1981, 33:671-680
64. Kaplan C, Benirschke K, Johnson KC: Leiomyomatosis peritonealis disseminata with endometrium. Obstet Gynecol 1980, 55:119-122
65. Kuo T, London SN, Dinh TV: Endometriosis occurring in leiomyomatosis peritonealis disseminata: ultrastructural study and histogenetic consideration. Am J Surg Pathol 1980, 4:197-204
66. Dracopli NC, Alhadeff B, Houghton AN, Old LJ: Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Cancer Res 1987, 47:4995-5000
67. Gibbons RJ, Picketts DJ, Villard L, Higgs DR: Mutations in a putative global transcription regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome). Cell 1995, 80:837-845
68. Gibbons RJ, Suthers GK, Wilkie AO, Buckle VJ, Higgs DR: X-linked α-thalassemia/mental retardation (ATR-X) syndrome: localization to Xq12-q21.31 by X inactivation and linkage analysis. Am J Hum Genet 1992, 51: 1136-1149
69. Wengler GS, Cutler Allen R, Parolini O, Smith H, Conley ME: Non-random X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency. J Immunol 1993, 150: 700-704
70. Migeon BR, Moser HW, Moser AB, Axelman J, Sillence D, Norum RA: Adrenoleukodystrophy: evidence for X linkage, inactivation, and selection favoring the mutant allele in heterozygous cells. Proc Natl Acad Sci USA 1981, 78:5066-5070
71. Nilbert M, Heim S, Mandahl N, Flodérus U-M, Willén H, Mitelman F: Karyotypic rearrangements in 20 uterine leiomyomas. Cytogenet Cell Genet 1988, 49:300-304
72. Mark J, Havel G, Grepp C, Dahlenfors R, Wedell B: Chromosomal patterns in human benign uterine leiomyomas. Cancer Genet Cytogenet 1990, 44:1-13
73. Pandis N, Heim S, Bardi G, Flodérus U-M, Willén H, Mandahl N, Mitelman F: Chromosome analysis of 96 uterine leiomyomas. Cancer Genet. Cytogenet 1991, 55:11-18
74. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC: Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991, 77:923-926
75. Meloni AM, Surti U, Contento AM, Davare J, Sandberg AA: Uterine leiomyomas: cytogenetic and histologic profile. Obstet Gynecol 1992, 80:209-217
76. Nilbert M, Heim S, Mandahl N, Foldrus UM, Willén H, Mitelman F: Characteristic chromosome abnormalities, including rearrangements of 6p, del(7q), +12, and t(12;14), in 44 uterine leiomyomas. Hum Genet 1990, 85:605-611
77. Schoenberg Fejzo M, Ashar HR, Krauter KS, Powell WL, Rein MS, Weremowicz S, Yoon S-J, Kucherlapati RS, Chada K, Morton CC: Translocation breakpoints upstream of the HMGI-C gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas. Genes Chromosomes & Cancer 1996, 17:1-6
78. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz SM, CC, Chada K: Disruption of the architectural factor HMGI-C: DMA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995, 82:57-65
79. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ: Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours, Nature Genet 1995, 10:436-443
80. Ozisik YY, Meloni AM, Surti U, Sandberg AA: Deletion 7q22 in uterine leiomyoma: a cytogenetic review. Cancer Genet Cytogenet 1993, 71:1-6
81. Ozisik YY, Meloni AM, Powell M, Surti U, Sandberg AA: Chromosome 7 biclonality in uterine leiomyoma. Cancer Genet Cytogenet 1993, 67:59-64
82. Fryns JP, Haspeslagh M, de Muelenaere A: Van den Berghe H: 9p Trisomy/18p distal monosomy and multiple cutaneous leiomyomata: another specific chromosomal site (18pter) in dominantly inherited multiple tumors? Hum Genet 1985, 70:284-286
83. Mark J, Havel G, Dahlenfors R, Wedell B: Cytogenetics of multiple uterine leiomyomas, parametrial leiomyoma, and disseminated peritoneal leiomyomatosis, Anticancer Res 1991, 11:33-40
84. Hendrickson MR, Kempson RL: Surgical pathology of the uterine corpus, Major Problems in Pathology, Edited by JL Bennington. Philadelphia, WB Saunders, 1980, pp 468-529